BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6392091)

  • 1. Transmissible drug resistance in Proteus mirabilis.
    Rao RS; Sundaraj T; Subramanian S
    Indian J Pathol Microbiol; 1984 Jan; 27(1):37-42. PubMed ID: 6392091
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pseudomonas aeruginosa and Proteus sensitivity to antibiotics and their combinations when cultured together].
    Sheina EP; Arutcheva AA
    Antibiotiki; 1983 May; 28(5):331-5. PubMed ID: 6410984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibiotic sensitivity of the H- and O-forms of bacteria in the genus Proteus].
    Nesterova GN; Leont'eva AN; Savinova VM
    Antibiotiki; 1978 Sep; 23(9):802-4. PubMed ID: 358911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transition of DNA with R factor NR84].
    Goto N; Rownd RH; Appelbaum E
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):188. PubMed ID: 765551
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevalence of Proteus mirabilis strains in clinical specimens and evaluation of their resistance to selected antibiotics].
    Sekowska A; Janicka G; Wróblewska J; Kruszyńska E
    Pol Merkur Lekarski; 2004 Nov; 17(101):538-40. PubMed ID: 15754653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic policy and bacterial resistance].
    Snijder JA
    Ned Tijdschr Geneeskd; 1978 Dec; 122(50):1958-62. PubMed ID: 364322
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of Proteus resistance to chloramphenicol].
    Shvidenko IG
    Antibiotiki; 1979 May; 24(5):345-8. PubMed ID: 375826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interrelationship between Proteus mirabilis proticin type and its resistance to antibiotics].
    Nieradko J
    Przegl Epidemiol; 1977; 31(1):23-7. PubMed ID: 329359
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation into the antibacterial activity in vitro of cement-antibiotic mixtures.
    Greco F; Rossi A; De Palma L; Spagnolo N
    Ital J Orthop Traumatol; 1981 Apr; 7(1):103-13. PubMed ID: 6799427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Inducible tetracycline resistance in R+ and R- strains of Proteus mirabilis.
    Hesslewood SR
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():45P. PubMed ID: 2719
    [No Abstract]   [Full Text] [Related]  

  • 11. Occurrence of extended-spectrum (beta)-lactamases and plasmid-mediated AmpC (beta)-lactamases among Korean isolates of Proteus mirabilis.
    Park YJ; Lee S; Kim YR; Oh EJ; Woo GJ; Lee K
    J Antimicrob Chemother; 2006 Jan; 57(1):156-8. PubMed ID: 16284101
    [No Abstract]   [Full Text] [Related]  

  • 12. R-plasmid mediated drug resistance to Proteus species.
    Gupta A; Arora DR; Chandna R; Ichhpujani RL
    J Commun Dis; 1984 Dec; 16(4):311-6. PubMed ID: 6535789
    [No Abstract]   [Full Text] [Related]  

  • 13. Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene.
    Vourli S; Tsorlini H; Katsifa H; Polemis M; Tzouvelekis LS; Kontodimou A; Vatopoulos AC
    Clin Microbiol Infect; 2006 Jul; 12(7):691-4. PubMed ID: 16774572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential integration sites of the Salmonella genomic island 1 in Proteus mirabilis and other bacteria.
    Doublet B; Golding GR; Mulvey MR; Cloeckaert A
    J Antimicrob Chemother; 2007 Apr; 59(4):801-3. PubMed ID: 17293370
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
    J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased mutability to fosfomycin resistance in Proteus mirabilis clinical isolates.
    Fonseca MRB; Sato JL; Lima-Noronha MA; Migliorini LB; Fernández-Silva FS; Galhardo RS
    Infect Genet Evol; 2018 Mar; 58():27-33. PubMed ID: 29248795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent data on the molecular structure of the antibiotic resistance factor (factor R)].
    Antiohi S; Lenghel Z
    Stud Cercet Virusol; 1973; 24(5):391-405. PubMed ID: 4583739
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides.
    McCoy AJ; Liu H; Falla TJ; Gunn JS
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2030-7. PubMed ID: 11408219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Persistence and reversion of stable L forms of Proteus mirabilis in white mice].
    Toshkov A; Kuiumdzhiev A; Gumpert I; Sotirova D
    Acta Microbiol Virol Immunol (Sofiia); 1977; 6():35-41. PubMed ID: 343510
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of plasmid-encoded extended spectrum beta-lactamases produced by a clinical strain of Proteus mirabilis.
    Mahrouki S; Ben-Achour N; Chouchani C; Ben-Moussa M; Belhadj O
    Pathol Biol (Paris); 2009 May; 57(3):e55-9. PubMed ID: 18456422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.